These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2179694)

  • 21. [Lansoprazole: an analysis of the clinical trials in the 3 years of 1997-1999].
    Dobrilla G; Capurso L
    Recenti Prog Med; 2000 Apr; 91(4):191-210. PubMed ID: 10804753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omeprazole in the treatment of peptic ulcers and gastroesophageal reflux disease.
    Cappell MS
    N J Med; 1992 Oct; 89(10):762-4. PubMed ID: 1461581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric carcinoid tumours in patients with Zollinger-Ellison syndrome on long-term omeprazole.
    Goldfain D; le Bodic MF; Lavergne A; Galian A; Modigliani R
    Lancet; 1989 Apr; 1(8641):776-7. PubMed ID: 2564577
    [No Abstract]   [Full Text] [Related]  

  • 25. Omeprazole.
    Maton PN
    N Engl J Med; 1991 Apr; 324(14):965-75. PubMed ID: 2002819
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experience in the use of losek (omeprazole) in gastroenterology].
    Maev IV; V'iuchnova ES; Lebedev EG; Dicheva DT; Ovsiannikova EV; Antonenko OM; Shchekina MI
    Ter Arkh; 2001; 73(7):79-82. PubMed ID: 11523419
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cimetidine].
    Castro Lde P; Salgado JA
    AMB Rev Assoc Med Bras; 1981 Oct; 27(10):301-4. PubMed ID: 7045988
    [No Abstract]   [Full Text] [Related]  

  • 28. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
    Bulgakov SA
    Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
    [No Abstract]   [Full Text] [Related]  

  • 29. Omeprazole.
    Walan A
    Baillieres Clin Gastroenterol; 1988 Jul; 2(3):629-40. PubMed ID: 3048454
    [No Abstract]   [Full Text] [Related]  

  • 30. Summary of the 34th meeting of the Food and Drug Administration Gastrointestinal Drugs Advisory Committee. March 15 and 16, 1989 (omeprazole and domperidone).
    Stern WR
    Am J Gastroenterol; 1989 Nov; 84(11):1351-5. PubMed ID: 2816869
    [No Abstract]   [Full Text] [Related]  

  • 31. Omeprazole: a novel antisecretory agent for the treatment of acid-peptic disorders.
    Lampkin TA; Ouellet D; Hak LJ; Dukes GE
    DICP; 1990 Apr; 24(4):393-402. PubMed ID: 2183494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Omeprazole. Its pharmacology and therapeutic efficacy].
    Protzer U; Holtermüller KH
    Dtsch Med Wochenschr; 1993 Feb; 118(7):230-9. PubMed ID: 8440164
    [No Abstract]   [Full Text] [Related]  

  • 33. The safety of proton pump inhibitors.
    Waldum HL
    Aliment Pharmacol Ther; 2001 May; 15(5):729-30. PubMed ID: 11328270
    [No Abstract]   [Full Text] [Related]  

  • 34. [Omeprazole in peptic ulcer--pros and cons].
    Stasiewicz J
    Wiad Lek; 1986 Jun; 39(11):765-71. PubMed ID: 3535259
    [No Abstract]   [Full Text] [Related]  

  • 35. [Substituted benzimidazoles--a new dimension in ulcer therapy?].
    Fimmel CJ; Blum AL
    Wien Klin Wochenschr; 1984 Feb; 96(4):149-53. PubMed ID: 6324498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Omeprazole long-term therapy: how great is the risk of developing a carcinoid tumor?].
    Koop H
    Z Gastroenterol; 1988 Dec; 26(12):769-71. PubMed ID: 3149827
    [No Abstract]   [Full Text] [Related]  

  • 37. Omeprazole.
    Friedman G
    Am J Gastroenterol; 1987 Mar; 82(3):188-91. PubMed ID: 3548325
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical efficacy and problems; gastric mucosa proton pump inhibitors].
    Okabe S; Akimoto Y
    Nihon Rinsho; 1988 Jan; 46(1):33-8. PubMed ID: 2836641
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anomalies of fundic argyrophil cell proliferation (enterochromaffin-like cells) in Zollinger-Ellison syndrome].
    Cadiot G; Lehy T; Ruszniewski P; Sobhani I; Vallot T; Mignon M
    Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):41C-46C. PubMed ID: 1916118
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Maton PN; Gardner JD; Jensen RT
    Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.